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Abstract: This study evaluated the anti-Toxoplasma gondii potential of gold, silver, and 
platinum nanoparticles (NPs). Inorganic NPs (0.01–1,000 µg/mL) were screened for antiparasitic 
activity. The NPs caused .90% inhibition of T. gondii growth with EC
50
 values of #7, #1, 
and #100 µg/mL for gold, silver, and platinum NPs, respectively. The NPs showed no host 
cell cytotoxicity at the effective anti-T. gondii concentrations; the estimated selectivity index 
revealed a $20-fold activity toward the parasite versus the host cell. The anti-T. gondii activity 
of the NPs, which may be linked to redox signaling, affected the parasite mitochondrial mem-
brane potential and parasite invasion, replication, recovery, and infectivity potential. Our results 
demonstrated the antiparasitic potential of NPs. The findings support the further exploration of 
NPs as a possible source of alternative and effective anti-T. gondii agents.
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Introduction
Toxoplasma gondii is an intracellular parasite belonging to the Apicomplexa family.1 
T. gondii is the causative agent of toxoplasmosis, which is one of the most common 
parasitic diseases.2 Toxoplasmosis is common because the parasite has low host speci-
ficity and therefore can infect a range of hosts, including nearly one-third of the human 
population.3 Toxoplasma infection can be asymptomatic in healthy individuals but 
fatal in pregnant or immunocompromised individuals; it has been linked to abortion, 
fetal abnormalities, and encephalitis in these individuals.4 In healthy individuals who 
are infected with Toxoplasma, the multiplication of the parasites is handled by the 
immune system and the administered drugs, but cysts remain in all infected tissues, 
including the brain, thereby serving as a source for exacerbations. Therefore, efficient 
treatment of all infected cells to prevent cyst formation is imperative.
Current treatment options for toxoplasmosis patients are limited. They include 
the use of antimalarial drugs or antibiotics, which often cause significant side effects, 
including bone marrow suppression and rashes.4 Current therapy for toxoplasmosis 
suppresses the active infection but does not cure the latent infection and is poorly 
tolerated. Without prolonged suppressive treatment, up to 80% of cases relapse, and 
20%–30% of patients on suppressive therapy relapse. The side effects of drugs have 
led to discontinuation of therapy in up to 40% of patients.3,5 Consequently, toxoplas-
mosis represents a large global burden that is further enhanced by the shortcomings 
of the current therapeutic options. These factors underscore the urgent need for better 
anti-Toxoplasma drugs and/or new approaches in the treatment of toxoplasmosis. 
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An ideal anti-Toxoplasma drug would be potent, nontoxic, 
and able to eliminate latent infection.
There is expanding interest in deploying nanotechnol-
ogy for biomedical purposes,6 and some reports suggest 
that nanoparticles (NPs) could form the bulk of future 
treatment strategies for various diseases.7,8 NPs are already 
being exploited for biomedical applications, due to their 
nanoscale size and other remarkable properties, including 
surface reactivity.9 These particles can produce reactive 
oxygen species (ROS) that have the ability to kill infectious 
agents.10,11 Furthermore, the small size of NPs allows them to 
transverse membrane barriers, leading to greater reactivity.12 
In addition, NPs could be accumulated in tissues,13 thereby 
presenting a formidable platform to target T. gondii cysts 
in host tissues. Of special interest are the metal NPs such 
as gold and silver, which have antimicrobial activity,14,15 
antiparasitic activity,16,17 and other bioactivities, including 
the selective inhibition of some enzyme activities.9,18–21 The 
versatility of metal NPs10 makes them an attractive choice 
to be explored further as antiparasitic agents, particularly 
against toxoplasmosis. Here, we explored the potential 
of metal NPs as novel anti-T. gondii agents using in vitro 
experimental infection models.
Materials and methods
Materials
Inorganic NPs, including gold NPs (AuNPs; 5 nm), silver NPs 
(AgNPs; 10 nm), and platinum NPs (PtNPs; 3 nm), were pur-
chased from (Sigma-Aldrich, St Louis, MO, USA). The NPs 
were used as supplied following characterization to confirm the 
supplier’s specification. The NPs were reconstituted in fresh 
culture medium prior to each use. All reagents were of analyti-
cal grade and used as supplied unless otherwise stated.
In vitro anti-T. gondii potential of 
metal NPs
Parasites
The T. gondii RH strain 2F22 was used for this study unless 
otherwise stated. The parasite was maintained by repeated 
passages in monolayers of human foreskin fibroblast (HFF) 
cells (American Type Culture Collection, Manassas, VA 
USA) cultured in Dulbecco’s Modified Eagle’s medium 
(DMEM; Nissui, Tokyo, Japan) supplemented with 
GlutaMAX™-I (Thermo Fisher Scientific Inc, St Louis, MO, 
USA), 10% (v/v) fetal calf serum (FCS; Gibco), and penicillin 
and streptomycin (100 U/mL; Thermo Fisher Scientific Inc). 
Host cells infected with T. gondii tachyzoites were passed 
through a 27 G needle to lyse them. The cell lysates were then 
filtered through a 5 µm filter to obtain a tachyzoite suspension 
free of host cell debris. The suspension was washed with fresh 
culture medium. Then, the parasite density was measured 
using a hemocytometer and adjusted for in vitro experimental 
infection analysis.
In vitro invasion and growth inhibition 
assessment by luciferase reporter assays
The number of T. gondii tachyzoites was determined using a 
luminescence-based assay of β-galactosidase (β-gal) activity 
expressed by the parasite strain RH-2F. To obtain a purified 
parasite suspension for the assays, infected cells were syringe 
released and the lysates were filtered to remove cell debris.
First, the anti-T. gondii EC
50
 and IC
50
 values for host 
cell toxicity were determined. In this preliminary assay, the 
NPs (AuNPs, AgNPs, and PtNPs) were screened at various 
concentrations ranging from 0.01 to 1,000 µg/mL. Based on 
the preliminary results, further experimental screening was 
done using concentrations of 15, 10, and 1,000 µg/mL for 
AuNPs, AgNPs, and PtNPs, respectively.
The growth inhibition assays and in vitro invasion assays 
were performed as described by Ishiwa et al.22 For the growth 
inhibition assay, purified parasite suspension was added to 
growing monolayers and invasion was allowed to occur for 
1 h. The medium was then removed, the monolayers were 
washed thoroughly, and fresh medium containing the NP solu-
tions (reconstituted in culture medium) was added. The mono-
layers were then incubated for 48 h. For the invasion assay, 
purified parasite suspension and the NP solutions (AuNPs, 
AgNPs, and PtNPs freshly reconstituted in culture medium) 
were added to the growing monolayers and incubated for 1 h 
to allow for invasion. The medium was then removed, the 
monolayers were washed thoroughly to remove uninvading 
parasites, and fresh medium was added. The monolayers 
were then incubated for 48 h. To assay invasion and growth 
inhibition, purified parasite suspension and the NP solutions 
(reconstituted in culture medium) were added to the growing 
monolayers and incubated for 48 h. The mock-treated (treat-
ment with NP vehicle; in this case, culture medium) cells 
served as a positive control, whereas the medium-only well 
was used to correct for any background signal noise. After 
48 h incubation at 37°C in a 5% CO
2
 atmosphere, the viabil-
ity of the RH-2F parasite strain was determined by assaying 
for galactosidase expression using a Beta-Glo® Luminescent 
Assay kit (Promega, Madison, WI, USA). The assay was per-
formed in triplicate and repeated three times. All experiments 
were performed in 96-well optical bottom plates (Nunc; Fisher 
Scientific, Pittsburgh, PA, USA) unless otherwise stated.
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host cell viability
cytotoxicity of metal NPs in mammalian cells
HFF cells were maintained in DMEM supplemented with 
GlutaMAX™-I, 10% (v/v) FCS, and penicillin and strepto-
mycin (100 U/mL). Cells were grown to confluence at 37°C 
in a 5% CO
2
 atmosphere. All experiments were performed 
in 96-well plates (Nunc) unless otherwise stated. At conflu-
ence, cells were trypsinized and resuspended to the desired 
cell density. The cells were seeded onto plates at a density of 
1×105 cells/well and incubated for 72 h followed by treatment 
with various concentrations (between 0.01 and 1,000 µg/mL) 
of the NPs (AuNPs, AgNPs, and PtNPs). Culture medium 
lacking the test compounds was added to the control well, 
and the medium only well was used to correct for any back-
ground signal noise. The treated cells were incubated for 
72 h before being subjected to the cell viability assay. All 
experiments were performed in 96-well plates (Nunc) unless 
otherwise stated.
Cell viability was determined using the CellTiter 96® 
AQueous One Solution Cell Proliferation Assay kit (Promega). 
Briefly, the well plate and its contents were equilibrated to 
room temperature. Then, 20 µL of the CellTiter 96® AQueous 
One reagent was added to each well. The contents were 
briefly mixed on an orbital shaker and then incubated at 37°C 
in a 5% CO
2
 atmosphere for 1–4 h. The absorbance signal 
was recorded at 490 nm using a microplate reader (MTP-
500; Corona Electric, Hitachinaka, Japan). The assay was 
repeated three times in triplicate. The results are given as 
the mean ± standard error of the mean (SEM; n=3) of three 
independent experiments.
Invasion and intracellular replication 
assessment by immunofluorescence (IF) 
staining
Invasion assay
Invasion assays were performed as described by Kieschnick 
et al23 and Sugi et al.24 Briefly, freshly harvested and puri-
fied parasites (1×105) were inoculated onto a monolayer of 
HFF cells on a coverslip for 1 h at 37°C with the different 
NP solutions (reconstituted in fresh medium prior to use) or 
medium only to serve as mock treatment. Following invasion, 
the cells were washed three times with ice-cold PBS, and 
extracellular parasites were stained with rabbit anti-T. gondii 
RH strain polyclonal antibodies (1:1,000) (Bio-Rad Labora-
tories, Hercules, CA, USA) in PBS containing 2% FCS for 
30 min on ice. The cells were then washed three times with 
PBS containing 2% FCS, fixed with 4% paraformaldehyde in 
PBS, and permeabilized with ice-cold methanol for 20 min. 
Then, the cells were washed three times with 2% FCS–PBS 
and further stained with monoclonal mouse anti-SAG1 anti-
bodies (1:1,000) (HyTest, Turku, Finland) in PBS containing 
2% FCS. Secondary staining was achieved by antibody solu-
tions containing Alexa 488 goat antimouse and Alexa 594 
goat antirabbit and DAPI for nuclear staining (1:1,000) in 
2% FCS–PBS. The cells were visualized with a fluorescence 
microscopy (Eclipse E400; Nikon, Tokyo, Japan). At least 
50 microscopic fields were chosen at random; extracellular 
parasites were detected using the rabbit anti-Toxoplasma 
antibodies, and the total parasites were detected with the 
mouse anti-SAG1 antibodies.
Intracellular replication assessment by IF staining
Intracellular replication assays were performed as described 
by Sugi et al.24 Briefly, purified parasites (1×105) were inocu-
lated onto growing HFF monolayers on a coverslip and incu-
bated at 37°C for 1 h to allow invasion. Cells were washed 
three times with warm culture medium to remove uninvaded 
parasites and were then incubated for different time periods 
(12, 16, 18, and 24 h) in medium containing NP solutions or 
medium only (mock treatment). After each incubation time 
period, the cells were fixed with 4% paraformaldehyde in 
PBS for 30 min at room temperature, permeabilized with 
ice-cold methanol for 20 min at room temperature, and then 
washed three times with PBS. The cells were blocked with 
2% BSA in 0.1% Tween 20–PBS for 1 h at room tempera-
ture. The primary antibody, monoclonal mouse anti-SAG1 
(1:1,000) in blocking buffer (0.1% Tween 20–PBS), was 
added and incubated for 30 min at 37°C. The cells were 
then washed three times (5 min between each wash) with 
blocking buffer. Secondary antibody solutions containing 
Alexa 546 goat antimouse and DAPI for nuclear staining 
in blocking buffer were added and incubated for 30 min at 
37°C. Coverslips were washed three times with PBS and 
viewed by fluorescence microscopy (Eclipse E400). At least 
50 microscopic fields were chosen at random to count the 
parasitophorous vacuoles. Average numbers of tachyzoites 
per vacuole were calculated.
reversibility
The reversibility of effect was assessed as described by 
Kamau et al.4 Briefly, invading parasites were grown in the 
presence of NP solutions (reconstituted in culture medium) 
for 12 and 24 h. The medium was removed, and the mono-
layer was washed thoroughly before adding fresh medium. 
The plate was then incubated in the absence of the NPs 
for another 24 h, and the growth curve was determined by 
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measuring the β-gal activity using the luminescent reporter 
assay. In parallel, after each incubation (12 and 24 h) of 
invading parasites in the presence of the NP solutions, 
parasite viability was determined on the basis of lumines-
cence to compare and evaluate the ability of the parasites to 
recover from the treatment. Three independent assays were 
performed.
Infectivity and likely cellular target
A procedure previously described by Kamau et al4 was used. 
In brief, freshly lysed and purified parasites were treated 
for either 24 or 48 h at 37°C in 5% CO
2
 with either medium 
only or an NP solution (reconstituted in culture medium) 
and then washed three times with culture medium to remove 
the NPs. The treated parasites were used to infect fresh HFF 
monolayers by incubating them with the cells for 48 h, prior 
to assaying for growth using the luminescence reporter assay. 
Extracellular parasites were incubated with the various NPs 
for 12 h after which the parasites were harvested and used 
for infectivity tests as described earlier.
To determine whether effects on parasite growth were due 
to effects on the host cell, uninfected HFF monolayers were 
pretreated for 24 h at 37°C in 5% CO
2
 with either medium 
only or an NP solution. The pretreated host monolayers were 
washed thoroughly with fresh medium. Freshly lysed and 
purified parasites were then allowed to invade the pretreated 
monolayers for 4 h, the monolayer was washed three times 
with medium, and parasite growth was allowed to proceed for 
24 h. Growth curves were determined using the luminescence 
reporter assay. In parallel, media-pretreated host cell mono-
layers were infected with parasites in a similar fashion, but 
the NP solutions were added 4 h postinvasion and incubated 
for 24 h. This allowed comparisons of the effects of the NPs 
after pretreatment to the effects of having the NPs present 
for the entire incubation period.
Measurement of intracellular rOs
Measurement of intracellular ROS was based on the 
intracellular peroxide-dependent oxidation of 2′,7′-dichlo-
rodihydrofluorescein diacetate (H
2
DCF-DA; Sigma, 
St Louis, MO, USA) to form the fluorescent compound 
2′,7′-dichlorofluorescein (DCF), as previously described by 
Warleta et al.25 Briefly, growing HFF monolayers were infected 
with purified parasite suspension and incubated for 24 h at 
37°C. Subsequently, the parasite-infested HFF cells were 
treated with the NPs and further incubated for 8 h at 37°C. 
The parasites were then harvested, purified, and resuspended 
in PBS containing the H
2
DCF-DA to a final concentration of 
100 µM. The parasite suspension containing the fluorescent 
dye was incubated for 30–60 min at 37°C. Fluorescence 
acquisition was then assessed using a spectrofluorometer 
(Corona Electric) with excitation set at 485 nm and emission 
at 530 nm. H
2
O
2
 was included as a positive control.
Measurement of the mitochondrial 
membrane potential
The measurement of mitochondrial membrane potential was 
acquired by spectrofluorimetry according to a procedure 
described by Baracca et al.26 Briefly, growing HFF monolayers 
were infected with purified parasite suspension and incubated 
for 24 h at 37°C. The parasite-infested HFF monolayers were 
treated with the NPs and further incubated for 8 h at 37°C. 
The parasites were then harvested, purified, and stained with 
200 nM MitoRed (Dojindo Molecular Technologies Inc, 
Kumamoto, Japan) by following the manufacturer’s protocol. 
Fluorescence acquisition was assessed using a spectrofluorom-
eter with excitation set at 560 nm and emission at 580 nm.
Data analysis
Data were analyzed using a one-way ANOVA (GraphPad 
Software Inc, San Diego, CA, USA) and are presented as 
the mean ± SEM. Comparisons among groups were deter-
mined using a one-way ANOVA and Dunnett’s posttest. 
P-value ,0.05 was considered to be statistically significant. 
The EC
50
 was estimated by plotting NP concentrations ver-
sus the percentages of T. gondii viability, and the IC
50
 was 
estimated by plotting NP concentrations versus the percent-
ages of cell viability. All the experiments were developed in 
the same conditions thrice separately, and the results were 
expressed as the mean ± SEM. Selectivity indexes (SIs) were 
also estimated. The analyses were carried out using Prism 
5 (Graphpad Software Inc), whereas nonlinear regression 
analysis was used to fit the curve. All experiments were 
performed in triplicate and carried out three times indepen-
dently unless otherwise stated.
Results
NPs significantly reduced the parasite 
growth
In our preliminary experiments, we sought to establish the 
antiparasitic activity and host cell cytotoxic potential of the 
metal NPs. Therefore, first, we screened the NPs (AuNPs, 
AgNPs, and PtNPs) at various concentrations between 0.01 
and 1,000 µg/mL for anti-T. gondii activity by incubating 
freshly lysed and purified parasites with the NPs in growing 
monolayers for 48 h. Parasite growth curves were determined 
International Journal of Nanomedicine 2017:12 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1651
anti-Toxoplasma activity of nanoparticles
by measuring the β-gal activity of the viable parasites 
using a luciferase reporter assay. The NPs significantly 
reduced the parasite viability by .90% (Figure 1) with EC
50
 
values of #7, #1, and #100 µg/mL for AuNPs, AgNPs, and 
PtNPs, respectively (Table 1). AuNPs and AgNPs showed a 
stronger anti-T. gondii activity relative to that of PtNPs, con-
sistent with other studies,14–17 that have reported antimicrobial 
and/or antiparasitic properties of AuNPs and AgNPs; similar 
studies using PtNPs were scarce in the literature. A reference 
drug (sulfadiazine, used to treat active toxoplasmosis), which 
was included as a positive control, decreased the parasite 
viability by .95%. This is consistent with published data27 
and thus supports the validity of our screening assay. The 
estimated IC
50
 values in our host cell cytotoxicity studies 
were $260, $48, and $2,000 µg/mL for AuNPs, AgNPs, 
and PtNPs, respectively. Estimation of the ratio of the host 
cell cytotoxic IC
50
 value to the antiparasite EC
50
 value as a 
measure of the therapeutic or SI was promising, with the 
SIs of $30, $40, and $20 for AuNPs, AgNPs, and PtNPs, 
respectively. Having established the EC
50
 values for the NPs, 
we performed further experiments using the single concen-
trations of 15, 10, and 1,000 µg/mL for AuNPs, AgNPs, 
and PtNPs, respectively, unless otherwise stated. Having 
determined that the NPs at these concentrations showed no 
host cell toxicity (Figure 2A), we screened them at these 
concentrations for T. gondii growth inhibition using the β-gal 
expressing luciferase reporter system. The results showed 
that the NPs induced .90% growth inhibition (Figure 2B). 
Next, we sought to determine whether the parasite invasion 
and growth processes were affected by treatment with NPs, 
using the luciferase reporter assay system. The data revealed 
that the NPs reduced parasite growth by .60% (Figure 2C) 
and suggest that the NPs may act during the parasite inva-
sion window. This finding could serve as an indirect measure 
of the parasite invasion efficiency in the presence of NPs. 
The data from the invasion and growth assay, in which the 
NPs were present throughout the 48 h incubation period, 
showed a .90% reduction in parasite viability relative to 
Figure 1 Preliminary screening of the nanoparticles at various concentrations for anti-Toxoplasma gondii activity to determine ec50 values.
Notes: (A) AuNP. (B) AgNP. (C) PtNP. Experiment was in triplicate and performed three times independently.
Abbreviations: agNP, silver nanoparticle; auNP, gold nanoparticle; ec50, concentration that inhibits 50% of Toxoplasma gondii growth; PtNP, platinum nanoparticle; seM, 
standard error of the mean.
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NPs have a direct anti-T. gondii activity, we incubated freshly 
lysed and purified parasites with the NPs for 12 h extracel-
lularly. Relative to the mock treatment, the NPs significantly 
(P,0.05) reduced the parasite viability (Figure 2E), compa-
rable to the results obtained when the parasite viability screen-
ing was done using the host monolayer, lending credence 
to the antiparasitic action of the NPs. Efforts to determine 
whether the NPs were inducing cyst formation rather than 
killing the parasite (using CST1 staining; data not shown) 
revealed the absence of cyst formation and thus supported the 
concept that treatment with NPs killed the parasites.
Poor infectivity and recovery following 
NP treatment
First, we sought to assess whether the NP-treated parasites 
could sustain their ability to infect fresh host monolayers. 
Table 1 Inorganic nanoparticles show strong activity against 
Toxoplasma gondii versus a host cell
Treatment  
group
EC50 value  
(RH-2F) (µg/mL)
IC50 (HFF)  
(µg/mL)
SI
auNP #7 $260 $30
agNP #1 $48 $40
PtNP #100 $2,000 $20
Notes: Values are expressed as the mean ± SEM (n=3). Each experiment was in 
triplicate and performed three times independently. rh-2F is a strain of Toxoplasma 
gondii.
Abbreviations: agNP, silver nanoparticle; auNP, gold nanoparticle; ec50, 
concentration that inhibits 50% of Toxoplasma gondii growth; hFF, human foreskin 
fibroblast; IC50, concentration that produces 50% of cellular inhibition; PtNP, 
platinum nanoparticle; seM, standard error of the mean; sI, selectivity index.
Figure 2 (A) In the absence of Toxoplasma gondii infection, the host monolayers were treated with NPs at the effective anti-T. gondii concentration and cell viability was 
determined after 72 h incubation. (B) Freshly lysed and purified parasites were allowed to invade growing HFF cells for 1 h. The infection medium was then removed, and fresh 
medium containing NPs was added. After 48 h incubation, growth inhibition was determined using a luciferase reporter assay. (C) Purified parasite suspension and NPs were 
added to growing hFFs and incubated for 1 h. Then the infection medium was replaced with fresh medium, and the cells were incubated for an additional 48 h. growth inhibition 
was determined using a luciferase reporter assay. (D) Purified parasite suspension and NPs were added to growing HFF monolayers and incubated for 48 h before growth 
curves were prepared based on data from a luciferase reporter assay system. (E) Freshly purified parasites were incubated with NPs under extracellular conditions for 12 h.
Notes: The data are expressed as the mean ± SEM (n=3). α is significant at P,0.05 relative to the control. experiment was in triplicate and performed three times 
independently.
Abbreviations: AgNP, silver nanoparticle; AuNP, gold nanoparticle; HFFs, human foreskin fibroblasts; PtNP, platinum nanoparticle; SEM, standard error of the mean; NPs, 
nanoparticles.
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mock treatment (Figure 2D). The results are similar to those 
obtained for the growth only assay, in which the purified 
parasites were allowed to invade the host monolayers for 1 h 
before the addition of the NPs. To further confirm that the 
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Freshly lysed and purified parasites were incubated with the 
NPs in growing host monolayers for 24 and 48 h. At each 
time point, the parasites were harvested and used to infect 
fresh host cells. After 48 h incubation, the parasite viability 
was determined. The results showed that treatment with the 
NPs at both time points negatively (P,0.05) impacted parasite 
infectivity (Figure 3A and B). NP treatment produced a .75% 
reduction in parasite infectivity potential relative to mock treat-
ment. In parallel, for comparison, we determined the parasite 
infectivity potential using extracellular parasites exposed to the 
NPs for 12 h. The data showed a similar trend of significant 
depression of the parasite infectivity by the NPs (Figure 3C). 
This finding thus confirms the antiparasitic action of the NPs. 
The poor infectivity potential exhibited by the parasites after 
treatment with the NPs could indicate unlikely reversible 
antiparasitic actions. Therefore, we evaluated whether the 
antiparasitic effect of NPs was reversible. Freshly lysed and 
purified parasites were incubated with the NPs in growing host 
monolayers for 12 and 24 h. At each time point, the NPs were 
removed and replaced with fresh medium, and the plates were 
incubated for a further 24 h after which parasite viability was 
determined. In parallel, parasite viability at 12 and 24 h of NP 
or mock treatment was determined to serve as the baseline for 
comparison. The data revealed a marginal recovery of ,10% 
following 24 h of NP treatment. Conversely, a slightly higher 
recovery of ,25% was observed for the 12 h NP treatment 
(Figure 4A and B). These data suggest that the NPs exhibit a 
minimally reversible but time-dependent antiparasitic action. 
It thus appears that the incubation time of the NPs with the 
parasites may play a role in determining whether the antipara-
sitic action may be reversible. Overall, our results indicate 
that the poor parasite infectivity potential may preclude the 
reversibility of the antiparasitic effects of the NPs.
The antiparasitic action of the NPs may 
be due, in part, to a parasite target
We then sought to determine whether the NPs affected 
parasite viability through a host or parasite target. Growing 
Figure 3 (A) Invading parasites were treated with nanoparticles (NPs) for 24 h after which the parasites were harvested and used to infect fresh HFF monolayers. 
(B) Invading parasites were treated with NPs for 48 h after which the parasites were harvested and used to infect fresh HFF monolayers. (C) Extracellular parasites were 
treated with NPs for 12 h after which the parasites were harvested and used to infect fresh hFF monolayers.
Notes: Parasite infectivity was determined after 48 h incubation. The data are expressed as the mean ± SEM (n=3). α is significant at P,0.05 relative to the control. 
experiment was in triplicate and performed three times independently.
Abbreviations: AgNP, silver nanoparticle; AuNP, gold nanoparticle; HFF, human foreskin fibroblast; PtNP, platinum nanoparticle; SEM, standard error of the mean.
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host cell monolayers were pretreated with the NPs for 24 h, 
and then freshly lysed and purified parasites were allowed 
to infect the pretreated host cells. After 24 h incubation, the 
parasite viability was determined. The data revealed .75% 
parasite growth in the host cells pretreated with the NPs 
relative to the mock pretreatment (Figure 4C). Although 
these findings suggest that the antiparasitic effects of NPs 
may be linked to a parasite target, we could not rule out 
the possibility that a host cell target also contributed to the 
observed anti-T. gondii activity of NPs. Of note, T. gondii 
growth in the host monolayers pretreated with AuNPs and 
PtNPs was significantly reduced by #20%.
NPs affect parasite invasion and 
replication
Toward unraveling the mode of the antiparasitic action of 
NPs, we sought to determine whether any stage of the para-
site lytic cycle was affected by the NPs. The parasite lytic 
cycle involves the following three repeated stages: invasion, 
replication, and egress. We assessed the effect of NPs on 
invasion and intracellular replication. The IF staining was 
used to assess the ability of the parasites to invade growing 
host monolayers and to determine the parasite number per 
vacuole in the presence of the NPs. The results revealed a 
significant reduction in parasite ability to invade growing 
Figure 4 (A) Invading parasites were treated with NPs for 12 h after which the medium was removed, the cells were washed thoroughly, and the medium was replaced. 
The cells were incubated for another 24 h after which the reversibility of treatment was evaluated through growth curve determinations. (B) Invading parasites were treated 
with NPs for 24 h after which the medium was removed, the cells were washed thoroughly, and the medium was replaced. The cells were incubated for another 24 h after 
which the reversibility of treatment was evaluated through growth curve determinations. (C) Growing HFF monolayers were pretreated with NPs for 24 h after which the 
pretreated host cells were washed thoroughly with fresh medium. Freshly purified parasites were then allowed to invade and infect the pretreated HFF monolayers, and the 
parasite growth potential was determined after 24 h.
Notes: The data are expressed as the mean ± SEM (n=3). α is significant at P,0.05 relative to the control. experiment was in triplicate and performed three times 
independently.
Abbreviations: AgNP, silver nanoparticle; AuNP, gold nanoparticle; HFF, human foreskin fibroblast; NP, nanoparticle; PtNP, platinum nanoparticle; SEM, standard error 
of the mean.
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host monolayers by .65, .60, and .50% for AuNPs, 
AgNPs, and PtNPs, respectively (Figure 5A). Similarly, the 
NPs caused .67% depletion in the average replication of 
parasites per vacuole (at least 100 vacuoles were counted per 
experiment) relative to the mock treatment (Figure 5B). These 
findings corroborate the data obtained from the invasion and 
growth assays using the luciferase reporter systems in which 
the NPs caused a .90% parasite growth inhibition. Further 
analyses at different time points (12, 16, 18, and 24 h) showed 
that NP treatment resulted in a time-dependent reduction in 
the number of parasites per vacuole (Figure 6A–D). More-
over, the highest number of parasites per vacuole was ,8 for 
the NPs relative to the mock treatment, for which the parasite 
number steadily increased with incubation time.
In support of the time-dependent depression of the 
capacity of the parasites to replicate, at the 24 h time point, 
the treatment with the NPs led to ,4 parasites per vacuole 
(Figure 7A–C), which was in stark contrast to the mock treat-
ment, where the number of parasites per vacuole gradually 
advanced to .24.
anti-T. gondii activity of NPs may be 
linked to altered redox status via 
intracellular production of rOs
Having established that the NPs possess anti-T. gondii 
activity, we sought to understand their likely mode of the 
antiparasitic action. First, we tested whether ROS play a 
role in the parasite killing capability of the NPs. In this 
experiment, we added an antioxidant, Trolox, to the NP 
antiparasite screening assay. The data showed that the anti-
parasitic effect of the NPs was mitigated in the presence of 
Trolox (Figure 8A–C). Although at the highest concentration 
(1,000 µg/mL), the addition of Trolox had no visible effect 
on the antiparasitic action of PtNPs. Nonetheless, the results 
indicate that the EC
50
 values for the NPs were increased in the 
presence of Trolox compared to that in the absence of Trolox. 
These findings implicate oxidative stress in the anti-T. gondii 
effect of the NPs. Although the reversal of the antiparasitic 
action of NPs through the addition of Trolox indicated a 
connection to oxidative stress, it was not a direct evaluation 
of the production of ROS. Therefore, we sought to directly 
determine whether ROS was produced during NP treatment 
of T. gondii. We monitored the production of ROS using 
H
2
DCF-DA, a cell-permeable reduced fluorescein that is 
nonfluorescent until its acetate groups are removed by intra-
cellular esterases during oxidation. Our results showed that 
AgNPs and PtNPs caused .100% ROS production relative 
to the nontreated control (Figure 9A and B). Similar results 
(.200% over the untreated control) were obtained following 
H
2
O
2
 treatment (data not shown), validating the ROS detec-
tion assay. Conversely, the level of ROS production induced 
by AuNP treatment was higher than the untreated control 
but not statistically significant. We then asked whether the 
NP-induced ROS production was sustained after remov-
ing the NPs. The results showed that ROS production was 
sustained following treatment with AuNPs or AgNPs for 
12 h after removing the NPs, suggesting that these NPs had 
a negative impact on the parasites.
Figure 5 IF staining of infected HFF cells that were treated with nanoparticles (NPs).
Notes: (A) Freshly purified parasite suspension and NPs were added to growing HFF monolayers on coverslips. Invasion was allowed for 1 h before IF staining. (B) Freshly 
purified parasite suspensions were added to growing HFF monolayers on coverslips. Invasion was allowed for 1 h after which the infection medium was replaced with fresh 
medium containing NPs. IF staining of intracellular parasites was carried out after 12 h incubation. The data are expressed as the mean ± SEM (n=3). α is significant at P,0.05 
relative to the control. experiment was performed three times independently.
Abbreviations: AgNP, silver nanoparticle; AuNP, gold nanoparticle; HFF, human foreskin fibroblast; IF, immunofluorescence; PtNP, platinum nanoparticle; SEM, standard 
error of the mean.
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Figure 6 IF staining to determine the number of parasites per vacuole following treatment with nanoparticles at the effective anti-Toxoplasma gondii concentration for 
different time periods.
Notes: (A) Mock treatment. (B) AuNP treatment. (C) AgNP treatment. (D) PtNP treatment. The data are expressed as the mean ± SEM (n=3). Experiment was performed 
three times independently.
Abbreviations: AgNP, silver nanoparticle; AuNP, gold nanoparticle; IF, immunofluorescence; PtNP, platinum nanoparticle; SEM, standard error of the mean.
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NPs decrease the parasite mitochondrial 
membrane potential
The mitochondria represent a major source of ROS in the 
cell. Indeed, mitochondria are considered as the major target 
of excess cellular ROS. We therefore asked whether NP-
induced ROS production affected the parasite mitochondria. 
We used MitoRed to evaluate the parasite mitochondrial 
membrane potential. MitoRed is a rhodamine-based dye 
that permeates cell membranes. It localizes in mitochondria 
and emits fluorescence. The interaction of MitoRed with 
the mitochondria is dependent on the membrane potential 
of the mitochondria. The 8 h treatment with the NPs led to 
reduced fluorescence intensity (Figure 10A and B), suggest-
ing low accumulation of the rhodamine-based dye in the 
parasite mitochondria. This finding may indicate that the 
treatment with the NPs affected the parasite mitochondria 
by decreasing their membrane potential. It was also found 
that 12 h after the NPs had been removed, the parasites 
may not have recovered from the NP-induced reduction 
in their mitochondrial membrane potential. This finding 
further supports the antiparasitic impact of NP treatment 
on parasite mitochondria.
Discussion
Our study demonstrates that AuNPs, AgNPs, and PtNPs have 
a promising anti-T. gondii activity without detectable host 
cell toxicity. We obtained antiparasite EC
50
 values of ,7, ,1, 
and ,100 µg/mL for AuNPs, AgNPs, and PtNPs, respec-
tively. Although the published reports of the antimicrobial 
and/or antiparasitic properties of PtNPs are limited, the EC
50
 
values obtained in our study are well within the range of 
those reported elsewhere16,17,28–30 for the antimicrobial and/or 
antiparasitic action exhibited by AuNPs and AgNPs. Inter-
estingly, a few of the studies17,29,30 reporting the antiparasitic 
activities of NPs revealed that under the same conditions, 
AgNPs had a lower EC
50
 value relative to that of AuNPs. 
A similar trend was observed in our studies that supports and 
further strengthens the promising antiparasitic potential of 
AuNPs and AgNPs. However, for PtNPs, a higher concentra-
tion was required to demonstrate the commensurate effective 
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Figure 7 (A) Number of parasites per vacuole at 24 hpi. IF staining to estimate the number of parasites based on 100 parasitophorus vacuoles after treatment with 
nanoparticles (NPs) at the effective anti-Toxoplasma gondii concentration. The data are expressed as the mean ± SEM (n=3). α is significant at P,0.05 relative to the 
control. Experiment was performed three times independently. (B) Representative fluorescent images showing replicating tachyzoites (RH-2F strain) only. (C) Replicating 
tachyzoites (RH-2F strain) with nuclear staining (DAPI) for the intracellular replication by IF assay. IF staining was performed at different time points following treatment with 
nanoparticles at the effective anti-T. gondii concentration. Mock treatment, culture medium only.
Abbreviations: AgNP, silver nanoparticle; AuNP, gold nanoparticle; IF, immunofluorescence; PtNP, platinum nanoparticle; SEM, standard error of the mean.
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anti-T. gondii activity. The absence of appreciable host cell 
toxicity induced by the NPs at the effective anti-T. gondii 
concentrations supports further exploration of the selective 
antiparasitic action of NPs. The estimated therapeutic or SI 
revealed $13-fold more activity against the parasite versus 
the host cell for AuNPs and AgNPs, whereas it was $7 
for PtNPs. This fact coupled with the absence of host cell 
toxicity induced by the NPs at the effective anti-T. gondii 
concentrations as well as the $75% parasite growth in host 
monolayers pretreated with the NPs suggests that these NPs 
have a partially selective antiparasitic action. Moreover, find-
ings obtained when extracellular tachyzoites were incubated 
for 12 h with the NPs not only reinforce that the NPs have 
anti-T. gondii activity but also confirm previous reports16,17 
demonstrating the antiparasitic potential of NPs. In addition, 
the poor recovery of parasites as well as the marginal parasite 
infectivity after treatment with NPs supports the further 
exploration of NPs as anti-infective agents. Together, these 
data show that NPs have favorable anti-T. gondii potential and 
thus support several earlier reports that demonstrated the anti-
Cryptosporidium parvum,28 antileishmanial,16 antifilarial,30 
antitrypanosomal, and antimalarial activities17 of AgNPs as 
well as the antiparasitic activity of AuNPs.17,30 However, this 
is the first report to show that AuNPs, AgNPs, and PtNPs 
can cause the death of T. gondii both within the host cell and 
extracellularly. Our findings attest to the promising potency 
of the NPs as antimicrobial,14,15 antiparasitic,17,29,30 and bioac-
tive agents,8,9,18,31 and may herald a turning point or revolution 
in pharmacological therapy for parasitic infections.
Our data confirm that NPs significantly impact the inva-
sion and replication stages of the parasite lytic cycle. These 
findings are preliminary and may represent early insights 
into how NPs restrict parasite growth. Although we do 
not yet know how or which of the processes that lead to 
parasite invasion of the host cell were impeded by the NPs 
(eg, association with the host plasma membrane, attachment 
to the host membrane, and host cell penetration32), our data 
provide evidence of a time-dependent reduction in parasite 
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Figure 9 effect of NPs on parasite redox status by measuring intracellular rOs production.
Notes: (A) The relative ROS level in the parasite was determined after 8 h of treatment with NPs. (B) The parasite-infected HFF monolayers were treated with NPs for 
8 h, after which the treatment was removed. The relative rOs level was determined 12 h after the removal of the NPs. The data are expressed as the mean ± SEM (n=6). 
The * is significant at P,0.0001 relative to the control. experiment was in triplicate and performed three times independently.
Abbreviations: agNP, silver nanoparticle; auNP, gold nanoparticle; NP, nanoparticle; PtNP, platinum nanoparticle; rOs, reactive oxygen species; seM, standard error of 
the mean.
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Figure 8 effect of Trolox on the anti-Toxoplasma gondii activity of the nanoparticles.
Notes: (A) AuNP. (B) AgNP. (C) PtNP. The data are expressed as the mean ± SEM (n=3). Experiment was in triplicate and performed three times independently.
Abbreviations: agNP, silver nanoparticle; auNP, gold nanoparticle; PtNP, platinum nanoparticle; seM, standard error of the mean; ec50, concentration that inhibits 50% 
of Toxoplasma gondii growth.
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vacuoles and in the number of parasites per vacuole, which, if 
considered together, suggest that treatment with NPs arrests 
T. gondii replication rather than slowing it. We are of the 
opinion that the depleting numbers of parasite vacuoles were 
unlikely to be a result of premature egress by parasites from 
the host cell because the host cell numbers did not appear to 
diminish and extracellular parasites were not observed. These 
findings suggest that the NPs may have induced a host cell-
mediated clearance of intracellular parasites through as yet 
unknown mechanisms.
Our findings also showed a significant reduction in the 
capacity of the parasites to successfully infect a fresh host 
after 24 or 48 h treatment with NPs, even though our data 
suggest that the antiparasitic effects of NPs may be margin-
ally reversible. The NP-induced paralysis of the potential of 
parasites to successfully infect fresh host monolayers is not 
unexpected because it is compatible with previously docu-
mented findings of the anti-infective potential of NPs.10,11 
It is possible that the poor parasite recovery following NP 
treatment stems from an NP-induced impact on parasite 
capacity for successful invasion and to a larger extent para-
site infectivity. Our data imply that the anti-T. gondii action 
of NPs may be partially linked to their ability to affect the 
invasion and replication stages of the parasite lytic cycle. 
Taken together, the antiparasitic actions displayed by the 
NPs in this study are consistent with published findings on 
the antimicrobial actions of the NPs reviewed by Yah and 
Simate33 and support the concept of exploring NPs as promis-
ing alternative anti-T. gondii agents.
Because nanomedicine is still in its infancy, the anti-
microbial and/or antiparasitic mode of action of the NPs 
is largely unknown. Our findings presented here implicate 
intracellular ROS in the parasite killing action of the NPs. The 
reversal of the antiparasitic action of NPs by Trolox suggested 
the involvement of oxidative stress in NP-induced killing of 
T. gondii; however, ROS measurement through the use of a 
fluorescent probe provided direct evidence that NP treatment 
promoted ROS production with a consequent contribution 
to NP-induced parasite death. These findings are consistent 
with the few reports that have shown that ROS generation 
by NPs, including AgNPs and AuNPs, is damaging, leading 
to the death of Leishmania major29 and causing the apoptotic 
killing of Filaria parasites.30
The lack of significant ROS production by AuNPs rela-
tive to the control may indicate that AuNP-induced ROS 
production was not a sudden burst of ROS production but 
rather a more extended process than that induced by AgNP 
or PtNP treatment. This concept is supported by the fact 
that after the NPs had been removed for 12 h, ROS produc-
tion due to AuNP treatment steadily increased. This finding 
demonstrates a connection between oxidative affront and the 
parasite killing potential of AuNPs. Furthermore, the finding 
that the ROS production induced by AuNPs and AgNPs was 
sustained for 12 h after removing the NPs indicates that the 
oxidative stress caused by the NP treatment may have resulted 
from extended generation of ROS rather than an immediate 
burst of ROS. The sustained oxidative stress may have been 
responsible for the growth arrest as well as for the death 
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Figure 10 effect of NPs on parasite mitochondrial membrane potential.
Notes: A cell-permeable rhodamine-based dye (MitoRed), which localizes to mitochondria and emits fluorescence, was used. The interaction of MitoRed with the 
mitochondria is dependent on the mitochondrial membrane potential. (A) The relative fluorescence intensity of MitoRed in parasite mitochondria after 8 h of treatment 
with NPs. (B) The parasite-infected HFF monolayers were treated with NPs for 8 h, after which the treatment was removed. The relative fluorescence intensity of MitoRed 
in the parasite mitochondria was evaluated 12 h after removal of the NPs. The data are expressed as the mean ± SEM (n=6). The * is significant at P,0.0001 relative to the 
control. experiment was in triplicate and performed three times independently.
Abbreviations: agNP, silver nanoparticle; auNP, gold nanoparticle; NP, nanoparticle; PtNP, platinum nanoparticle; seM, standard error of the mean.
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of the parasite. The sustained oxidative onslaught would 
be very injurious, causing appreciable damage to cellular 
biomolecules, and may fuel the antiparasitic potency of the 
NPs. In contrast, the ROS production after the removal of 
PtNPs for 12 h showed a drastic decline. At the moment, 
we may not be able to explain the reason for this observa-
tion. Nonetheless, the protection afforded by the addition of 
Trolox strongly accentuated the role of oxidative insult in the 
antiparasitic action of the NPs. Furthermore, the NP-induced 
ROS production after the removal of the NPs adds evidence 
in support of the antiparasitic effects of these NPs. Taken 
together, our findings indicate that the antiparasitic action of 
the NPs could, in part, be linked to the altered redox status 
possibly via ROS production. This would not be unexpected 
given existing reports demonstrating the in vitro and in vivo 
ROS-generating potential of inorganic NPs, including AuNPs 
and AgNPs.12,29,30 Our data are in full accord with the ROS-
inducing anti-infective character of NPs.10,11
In addition, our finding that treatment with NPs depleted 
the parasite mitochondrial membrane potential further rein-
forces our evidence for intracellular ROS production and 
its culpability in the antiparasitic action. The NP-induced 
decrease in the parasite mitochondrial membrane poten-
tial was sustained, even up to 12 h after the NPs had been 
removed. These data are consistent with the recent findings 
of Charvat and Arrizabalaga,34 which indicated that oxidative 
stress as a consequence of excess cellular ROS production 
was devastating to the parasite mitochondrial membrane 
potential and led to the death of T. gondii. Furthermore, these 
findings are consistent with several other reports that have 
shown that mitochondria are negatively affected by excess 
cellular ROS production, whereby ROS induces cell death 
by either promoting intrinsic apoptotic processes and/or 
activating cellular autophagy,35–37 all of which are possible 
routes to cell death as a result of NP-induced ROS production 
and/or altered redox status.
The finding that T. gondii succumbed to an NP-induced 
oxidative onslaught provides further evidence to strengthen 
the support for exploring compounds that can induce oxidative 
affront and/or interfere with parasite redox biology as a viable 
approach for the development of antiparasitic agents.
Conclusion
Our findings identify AuNPs, AgNPs, and PtNPs as promis-
ing anti-T. gondii candidates. To our knowledge, this is the 
first evidence of anti-T. gondii activity by AuNPs, AgNPs, 
and PtNPs. Furthermore, the antiparasitic action of these 
NPs could be linked, in part, to altered redox status via ROS 
production. These novel findings add to the growing body 
of data supporting the need to explore the potential of NPs 
within the nanomedical community. Further investigations, 
including in vivo evaluation as well as assessments of the 
anti-T. gondii potential of surface-modified NPs, are ongoing 
with a view toward developing a new and effective treatment 
strategy for acute and/or latent toxoplasmosis.
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